Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

التفاصيل البيبلوغرافية
العنوان: Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
المؤلفون: Stephan Stilgenbauer, Sebastian Böttcher, Hartmut Döhner, Ute Hegenbart, Norbert Schmitz, Lutz Uharek, Michael Stadler, Peter Dreger, Isabelle Krämer, Anthony D. Ho, Sascha Dietrich, Christof Scheid, Matthias Zeis, Michael Hallek, Jörg Thomas Bittenbring, Michael Kneba
المصدر: Blood. 130:1477-1480
بيانات النشر: American Society of Hematology, 2017.
سنة النشر: 2017
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chronic lymphocytic leukemia, Immunology, Salvage therapy, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Neoplasm, Hematopoietic cell, business.industry, Cell Biology, Hematology, medicine.disease, Transplantation, Leukemia, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Alemtuzumab, business, 030215 immunology, medicine.drug
تدمد: 1528-0020
0006-4971
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8fbadad1b8b01f25b15055a6900d847aTest
https://doi.org/10.1182/blood-2017-04-775841Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........8fbadad1b8b01f25b15055a6900d847a
قاعدة البيانات: OpenAIRE